Blue Jet Healthcare Limited (BOM:544009)
India · Delayed Price · Currency is INR 465.05
-10.75 (-2.26%)
At close: Jun 5, 2026
Blue Jet Healthcare Revenue
In the fiscal year ending March 31, 2026, Blue Jet Healthcare had annual revenue of 9.47B INR, down -8.03%. Blue Jet Healthcare had revenue of 2.35B in the quarter ending March 31, 2026, a decrease of -31.07%.
Revenue
9.47B
Revenue Growth
-8.03%
P/S Ratio
8.52
Revenue / Employee
48.33M
Employees
196
Market Cap
80.69B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 9.47B | -826.64M | -8.03% |
| Mar 31, 2025 | 10.30B | 3.18B | 44.74% |
| Mar 31, 2024 | 7.12B | -93.84M | -1.30% |
| Mar 31, 2023 | 7.21B | 375.13M | 5.49% |
| Mar 31, 2022 | 6.83B | 1.85B | 36.99% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jubilant Pharmova | 82.80B |
| Granules India | 53.66B |
| Viyash Scientific | 34.20B |
| Caplin Point Laboratories | 21.87B |
| FDC Limited | 21.71B |
| Sanofi India | 17.74B |
| Procter & Gamble Health | 14.08B |
| CORONA Remedies | 14.03B |